Consolidated Statements of Stockholders’ Investment - USD ($) $ in Thousands	12 Months Ended						186 Months Ended
	Jan. 30, 2021		Feb. 01, 2020		Feb. 02, 2019		Feb. 01, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ 328,983		$ 336,049		$ 319,596
Net income	74,266		27,344		28,421
Issuance of shares through the Company’s equity plans	1,858		475		901
Purchase of shares under the stock repurchase program	$ (16,717)		$ (34,904)		$ (16,124)		$ (662,800)
Settlement of net share equity awards (in shares)	42,449		29,432		18,765
Settlement of net share equity awards	$ (897)		$ (555)		$ (416)
Stock-based compensation	3,799		2,653		4,316
Balance-end of period	391,036		328,983		336,049		328,983
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ (256)	[1]	(2,079)	[2]	(645)	[3]
Balance-end of period			$ (256)	[1]	$ (2,079)	[2]	$ (256)	[1]
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)	39,141,000		38,983,000		38,863,000
Balance-beginning of period	$ 391		$ 390		$ 389
Issuance of shares through the Company’s equity plans (in shares)	239,000		158,000		120,000
Issuance of shares through the Company’s equity plans	$ 3		$ 1		$ 1
Balance-end of period (in shares)	39,380,000		39,141,000		38,983,000		39,141,000
Balance-end of period	$ 394		$ 391		$ 390		$ 391
Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	188,879		185,752		180,536
Issuance of shares through the Company’s equity plans	1,855		474		900
Stock-based compensation	3,799		2,653		4,316
Balance-end of period	194,534		188,879		185,752		188,879
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	784,942		759,677		731,901
Net income	74,266		27,344		28,421
Balance-end of period	858,951		784,942		759,677		784,942
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ (256)	[1]	(2,079)	[2]	(645)	[3]
Balance-end of period			$ (256)	[1]	$ (2,079)	[2]	$ (256)	[1]
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)	22,280,000		20,686,000		19,910,000
Balance-beginning of period	$ (645,229)		$ (609,770)		$ (593,230)
Purchase of shares under the stock repurchase program (in shares)	578,000		1,565,000		757,000
Purchase of shares under the stock repurchase program	$ (16,717)		$ (34,904)		$ (16,124)
Settlement of net share equity awards (in shares)	43,000		29,000		19,000
Settlement of net share equity awards	$ (897)		$ (555)		$ (416)
Balance-end of period (in shares)	22,901,000		22,280,000		20,686,000		22,280,000
Balance-end of period	$ (662,843)		$ (645,229)		$ (609,770)		$ (645,229)

[1] Adoption of ASU 2016-13, Topic 326, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. See Note 2, Recent Accounting Pronouncements, in this Annual Report on Form 10-K.

[2] Adoption of ASU 2016-02, Topic 842, Leases. See Note 2, Recent Accounting Pronouncements, in our Annual Report on Form 10-K filed on April 16, 2020.

[3] Adoption of Accounting Standards Update (ASU), Topic 606, Revenue from Contracts with Customers. See Note 2, Recent Accounting Pronouncements, in our Annual Report on Form 10-K filed on April 16, 2020.